406 related articles for article (PubMed ID: 19505629)
1. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.
Xie QP; Huang H; Xu B; Dong X; Gao SL; Zhang B; Wu YL
Differentiation; 2009 Jun; 77(5):483-91. PubMed ID: 19505629
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells.
Chang CF; Hsu KH; Chiou SH; Ho LL; Fu YS; Hung SC
J Biomed Mater Res A; 2008 Sep; 86(4):1097-105. PubMed ID: 18080299
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.
Wu LF; Wang NN; Liu YS; Wei X
Tissue Eng Part A; 2009 Oct; 15(10):2865-73. PubMed ID: 19257811
[TBL] [Abstract][Full Text] [Related]
5. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from human exocrine pancreas express transcription factors implicated in beta-cell development.
Baertschiger RM; Bosco D; Morel P; Serre-Beinier V; Berney T; Buhler LH; Gonelle-Gispert C
Pancreas; 2008 Jul; 37(1):75-84. PubMed ID: 18580448
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro.
Moriscot C; de Fraipont F; Richard MJ; Marchand M; Savatier P; Bosco D; Favrot M; Benhamou PY
Stem Cells; 2005 Apr; 23(4):594-603. PubMed ID: 15790780
[TBL] [Abstract][Full Text] [Related]
8. Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells.
Li HY; Chen YJ; Chen SJ; Kao CL; Tseng LM; Lo WL; Chang CM; Yang DM; Ku HH; Twu NF; Liao CY; Chiou SH; Chang YL
J Pharmacol Exp Ther; 2010 Dec; 335(3):817-29. PubMed ID: 20855446
[TBL] [Abstract][Full Text] [Related]
9. Expression of pancreatic endocrine markers by prolactin-treated rat bone marrow mesenchymal stem cells.
González P; Santos TM; Calil A; Corradi Perini C; Percegona LS; Silva IC; Kuligovski C; Aguiar AM; Câmara NO; Aita CA
Transplant Proc; 2010 Mar; 42(2):566-9. PubMed ID: 20304194
[TBL] [Abstract][Full Text] [Related]
10. New method to differentiate human peripheral blood monocytes into insulin producing cells: Human hematosphere culture.
Hur J; Yang JM; Choi JI; Yun JY; Jang JH; Kim J; Kim JY; Oh IY; Yoon CH; Cho HJ; Park YB; Kim HS
Biochem Biophys Res Commun; 2012 Feb; 418(4):765-9. PubMed ID: 22310720
[TBL] [Abstract][Full Text] [Related]
11. Generation of insulin-producing cells from rat mesenchymal stem cells using an aminopyrrole derivative XW4.4.
Ouyang J; Huang W; Yu W; Xiong W; Mula RV; Zou H; Yu Y
Chem Biol Interact; 2014 Feb; 208():1-7. PubMed ID: 24287272
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro.
Hu YH; Wu DQ; Gao F; Li GD; Zhang XC
Chin Med J (Engl); 2010 Mar; 123(5):606-14. PubMed ID: 20367990
[TBL] [Abstract][Full Text] [Related]
13. Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells.
Thatava T; Ma B; Rohde M; Mayer H
Stem Cells; 2006 Dec; 24(12):2858-67. PubMed ID: 16990588
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
[TBL] [Abstract][Full Text] [Related]
15. Insulin-producing cells from human pancreatic islet-derived progenitor cells following transplantation in mice.
Zhang Y; Ren Z; Zou C; Wang S; Luo B; Li F; Liu S; Zhang YA
Cell Biol Int; 2011 May; 35(5):483-90. PubMed ID: 21080910
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional differentiation of bone marrow-derived mesenchymal stem cells into insulin-producing cells.
Khorsandi L; Nejad-Dehbashi F; Ahangarpour A; Hashemitabar M
Tissue Cell; 2015 Feb; 47(1):66-72. PubMed ID: 25554603
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
Lin P; Chen L; Yang N; Sun Y; Xu YX
Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro.
Wang HW; Lin LM; He HY; You F; Li WZ; Huang TH; Ma GX; Ma L
Chin Med J (Engl); 2011 May; 124(10):1534-9. PubMed ID: 21740812
[TBL] [Abstract][Full Text] [Related]
19. Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study.
Zhang Y; Dou Z
Stem Cell Res Ther; 2014 May; 5(3):66. PubMed ID: 24887638
[TBL] [Abstract][Full Text] [Related]
20. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
